PERSPECTA

News from every angle

← Back to headlines

Aurobindo Pharma's Raleigh Plant Receives US FDA 'Voluntary Action Indicated' Classification

Aurobindo Pharma's manufacturing plant in Raleigh has been classified as 'Voluntary Action Indicated' by the US FDA.

17 Aug, 03:29 — 17 Aug, 03:29
PostShare

Sources

Showing 1 of 1 sources
economic-times2d ago

Aurobindo Pharma’s Raleigh plant gets 'Voluntary Action Indicated' classification from US FDA - The Economic Times

Aurobindo Pharma’s Raleigh plant gets 'Voluntary Action Indicated' classification from US FDA  The Economic Times

Read full article →

Related Stories

High Government Bond Yields Raise Alarm in Financial Markets

31m ago

Moderna and Merck's Melanoma Vaccine Shows Positive Results, Boosting Stock Prices

41m ago

Krško Nuclear Power Plant Resumes Full Operation After Shutdown

42m ago

Nigerian Government Plans Building Materials Hubs Across Geopolitical Zones

46m ago